Zeba N. Singh

Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer

Nidal Muvarak, Khadiza Chowdhury, Limin Xia et al. · Cancer Cell · 2016 · 207 citations · Full text

Cytotoxic Effects, A Potential Therapy, Medicine +8

Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma

Ashraf Badros, Elizabeth Hyjek, Ning Ma et al. · Blood · 2017 · 194 citations · Full text

Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy.

Frits van Rhee, Katie Stone, Susann Szmania et al. · PubMed · 2010 · 165 citations

Primary Immunodeficiency, Hiv-negative Cd, Viral Persistence +13

Therapy-Related Myelodysplastic Syndrome

Zeba N. Singh, Dezheng Huo, John Anastasi et al. · American Journal of Clinical Pathology · 2007 · 106 citations · Full text

Hematological Malignancy, World Health Organization, Oncology +13

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Saad Z. Usmani, Bijay Nair, Pingping Qu et al. · Leukemia · 2012 · 80 citations · Full text

Hematological Malignancy, Oncology, Gene-expression Profiling +15